TGFB1 and diabetic kidney disease: Studies demonstrated that inhibition of the TGF-β pathway reduced ECM deposition and attenuated fibrogenesis [78], whereas upregulated proinflammatory factors thus aggravated the inflammatory response [76], indicating a diverse role of TGF-β in the development of DKD.